Trial intelligence / Profile preview

Sanhua Gao transdermal therapy for perioperative swelling in tibial plateau fractures

ChiCTR2400082303Phase 4Not yet recruiting

Sponsor
Xi'an Honghui Hospital
Start
Mar 2024
Countries
1
01

Overview

Phase 4, open-label trial of Sanhua Gao in tibial plateau fracture (2 arms), sponsored by Xi'an Honghui Hospital. Primary endpoint: Swelling degree of the affected limb's lower leg. Planned start Mar 2024; status: not yet recruiting.

02

Drugs

Sanhua Gao
03

Conditions

tibial plateau fracture

Beyond the preview

Go deeper on ChiCTR2400082303.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400082303.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call